Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.4 USD | -53.80% | -57.12% | -32.14% |
Apr. 23 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Apr. 23 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | 17.85M | Sales 2025 * | 64.39M | Capitalization | 93.01M |
---|---|---|---|---|---|
Net income 2024 * | -52M | Net income 2025 * | -28M | EV / Sales 2024 * | 5.21 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.44 x |
P/E ratio 2024 * |
-3.83
x | P/E ratio 2025 * |
-7.69
x | Employees | 84 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.9% |
Latest transcript on Abeona Therapeutics Inc.
1 day | -53.80% | ||
1 week | -56.19% | ||
Current month | -53.10% | ||
1 month | -54.05% | ||
3 months | -30.18% | ||
6 months | -14.79% | ||
Current year | -32.14% |
Managers | Title | Age | Since |
---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 21-05-31 |
Michael Amoroso
CHM | Chairman | 46 | 20-07-08 |
Joseph Vazzano
DFI | Director of Finance/CFO | 40 | 22-03-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 56 | 06-02-28 |
Faith Charles
BRD | Director/Board Member | 62 | 21-03-24 |
Leila Alland
BRD | Director/Board Member | 61 | 21-04-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 7.36 | -2.77% | 1,028,038 |
24-04-19 | 7.57 | +0.53% | 386,264 |
24-04-18 | 7.53 | -5.04% | 245,982 |
24-04-17 | 7.93 | +2.19% | 729,644 |
24-04-16 | 7.76 | +1.57% | 218,567 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.14% | 201M | |
+3.13% | 42.11B | |
+48.83% | 40.08B | |
+8.49% | 40B | |
-10.82% | 26.87B | |
+8.26% | 24.58B | |
-23.69% | 18.44B | |
+1.58% | 11.94B | |
+32.83% | 11.66B | |
+6.63% | 11.01B |
- Stock Market
- Equities
- ABEO Stock